Literature DB >> 19835431

Insights from epidemiological game theory into gender-specific vaccination against rubella.

Eunha Shim1, Beth Kochin, Alison Galvani.   

Abstract

Rubella is a highly contagious childhood disease that causes relatively mild symptoms. However, rubella can result in severe congenital defects, known as congenital rubella syndrome (CRS), if transmitted from a mother to a fetus. Consequently, women have higher incentive to vaccinate against rubella than men do. Within the population vaccination reduces transmission but also increases the average age of infection and possibly the risk of CRS among unvaccinated females. To evaluate how the balance among these factors results in optimal coverage of vaccination, we developed a game theoretic age-structured epidemiological model of rubella transmission and vaccination. We found that high levels of vaccination for both genders are most effective in maximizing average utility across the population by decreasing the risk of CRS and reducing transmission of rubella. By contrast, the demands for vaccines driven by self-interest among males and females are 0% and 100% acceptance, respectively, if the cost of vaccination is relatively low. Our results suggest that the rubella vaccination by males that is likely to be achieved on voluntary basis without additional incentives would have been far lower than the population optimum, if rubella vaccine were offered separately instead of combined with measles and mumps vaccination as the MMR vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19835431     DOI: 10.3934/mbe.2009.6.839

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  10 in total

1.  The influence of altruism on influenza vaccination decisions.

Authors:  Eunha Shim; Gretchen B Chapman; Jeffrey P Townsend; Alison P Galvani
Journal:  J R Soc Interface       Date:  2012-04-11       Impact factor: 4.118

2.  A game dynamic model for vaccine skeptics and vaccine believers: measles as an example.

Authors:  Eunha Shim; John J Grefenstette; Steven M Albert; Brigid E Cakouros; Donald S Burke
Journal:  J Theor Biol       Date:  2011-11-15       Impact factor: 2.691

3.  Optimal H1N1 vaccination strategies based on self-interest versus group interest.

Authors:  Eunha Shim; Lauren Ancel Meyers; Alison P Galvani
Journal:  BMC Public Health       Date:  2011-02-25       Impact factor: 3.295

Review 4.  Optimal but unequitable prophylactic distribution of vaccine.

Authors:  Matt J Keeling; Andrew Shattock
Journal:  Epidemics       Date:  2012-03-07       Impact factor: 4.396

5.  Conflicts of interest during contact investigations: a game-theoretic analysis.

Authors:  Nicolas Sippl-Swezey; Wayne T Enanoria; Travis C Porco
Journal:  Comput Math Methods Med       Date:  2014-04-14       Impact factor: 2.238

6.  Treatment strategies for sheep scab: An economic model of farmer behaviour.

Authors:  Emily J Nixon; Hannah Rose Vineer; Richard Wall
Journal:  Prev Vet Med       Date:  2016-12-29       Impact factor: 2.670

7.  A game-theoretic model of Monkeypox to assess vaccination strategies.

Authors:  Sri Vibhaav Bankuru; Samuel Kossol; William Hou; Parsa Mahmoudi; Jan Rychtář; Dewey Taylor
Journal:  PeerJ       Date:  2020-06-22       Impact factor: 2.984

8.  Optimal voluntary and mandatory insect repellent usage and emigration strategies to control the chikungunya outbreak on Reunion Island.

Authors:  Sylvia R M Klein; Alex O Foster; David A Feagins; Jonathan T Rowell; Igor V Erovenko
Journal:  PeerJ       Date:  2020-12-17       Impact factor: 2.984

9.  The interplay of public intervention and private choices in determining the outcome of vaccination programmes.

Authors:  Alberto d'Onofrio; Piero Manfredi; Piero Poletti
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Ebola could be eradicated through voluntary vaccination.

Authors:  Andrew Brettin; Rosa Rossi-Goldthorpe; Kyle Weishaar; Igor V Erovenko
Journal:  R Soc Open Sci       Date:  2018-01-24       Impact factor: 2.963

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.